CAS: 34597-40-5; Calcium 2-(3-Phenoxyphenyl)Propanoate
该化合物是一种主要用于其止痛和抗炎特性的非类固醇抗炎药物,是一种氟丙酮的钙盐,是一种丙丙酸衍生物,其特点是,这种物质通常用于减轻与关节炎和其他肌肉骨骼疾病等条件相关的疼痛和炎痛,通过抑制环氧酶(COX)酶(NSAID),这种酶在合成具有介质和疼痛作用的蛋白质欧洲复合体方面起着关键作用,其特点是,由于有钙离子,这种物质在水中的溶性相对较高,这提高了其生物利用率,常见副作用包括胃肠炎和其他肌肉骨骼疾病等,与其他非氨基ID一样,在医疗监督下使用Fenoprofen 钙,以管理剂量和监测不良的治疗和监测,特别是作为治疗前的治疗性疼痛的病人,作为治疗前的治疗;在治疗前的治疗中,必须使用胎儿胆碱,作为有效的治疗,作为治疗前治疗结果.
- 英文名称Calcium 2-(3-Phenoxyphenyl)Propanoate
- 中文名称非诺洛芬钙
- IUPAC名称calcium 2-(3-phenoxyphenyl)propanoate
- 其它别名(+-)-Alpha-Methyl-3-Phenoxybenzeneaceticacidcalciumsalt; Alpha-Methyl-3-Phenoxy-,Calciumsalt,(+-)-Benzeneaceticaci; Calciumfenoprofen; Dl-2-(3-Phenoxyphenyl)Propionicacidcalciumsalt; Nalfon; Fenoprofen Calcium Salt; Calcium (±)-Bis[2-(3-Phenoxyphenyl)Propionate]; Fepron
- CAS编号34597-40-5
- MFCD编号:MFCD00079289
- EINECS号:252-107-9
- FDA UNII编号:8R95A3O51K
- 分子式:C30H26CaO6分子量:522.61
- 产品CID: 1349836
- 同类组份化合物CAS29679-58-1 (free acid)34597-40-5 (calcium)71720-56-4 (hydrate)
- 产品分类有机原料 → 苯类化合物 → 苯和取代衍生物
物理性质
MSDS等安全信息
欧盟法规
C&L通报REACH预注册合成工艺路线路线简述
海关参考信息
- 2902600000-乙苯
2902700000-异丙基苯
2905121000-正丙醇
2912110000-甲醛 - 💡 提示：海关信息按照顺序优先匹配，如需确认的海关信息，请参考相关资料。
- 详情请参考：📖 海关编码查询和海关进出口税则
专利信息
专利号:US-8697730-B2
优先权日:2007-10-26
标题 :5-lipoxygenase activating protein (FLAP) inhibitor
发明人：REWOLINSKI MELISSA VIRGINIA; SCHAAB KEVIN MURRAY; KING CHRISTOPHER DAVID; STOCK NICHOLAS SIMON
权利人:REWOLINSKI MELISSA VIRGINIA; SCHAAB KEVIN MURRAY; KING CHRISTOPHER DAVID; STOCK NICHOLAS SIMON; PANMIRA PHARMACEUTICALS LLC
摘要:Described herein are methods for the synthesis of 3-[5-(pyridin-2-ylmethoxy)-3-(2-methyl-2-propylthio)-1-[4-(2-methoxypyridin-5-yl)benzyl]-indol-2-yl]-2,2-dimethyl-propionic acid, pharmaceutically acceptable salts, pharmaceutically acceptable solvates thereof. Also described are pharmaceutical compositions suitable for oral administration to a mammal that include, as well as methods of using such oral pharmaceutical compositions for treating respiratory conditions or diseases, as well as other leukotriene-dependent or leukotriene mediated conditions or diseases.
专利号:KR-20160017105-A
优先权日:2008-01-15
标题:Synthesis of resorcylic acid lactones useful as therapeutic agents
专利号:RU-2534527-C2
优先权日:2008-01-15
标题 :Synthesis of resorcylic acid lactones used as therapeutic agents
专利号:WO-2009091921-A1
优先权日:2008-01-15
标题:Synthesis of resorcylic acid lactones useful as therapeutic agents
专利号:JP-6159350-B2
优先权日:2008-01-15
标 题:Synthesis of resorcinic acid lactones useful as therapeutic agents
专利号:KR-20160112016-A
优先权日:2008-01-15
标题:Synthesis of resorcylic acid lactones useful as therapeutic agents
供应商参考报价(招募中)
品牌试剂参考报价(招募中)
📌 第三方产品分析报告
合成参考文献
摘要:Kiso to Rinsho. Clinical Report., 14(4385), 1980
📝 需求与反馈
尽可能描述清楚需求与问题信息
